Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial

Published:2003-01 Issue:1 Volume:145 Page:179-186
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Russell Stuart D.,Selaru Paulina,Pyne David A.,Ghazzi Maha M.,Massey Kenneth D.,Pressler Milton,Serikoff Alexis,Coats Andrew J.S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The bumpy road to drug development for acute heart failure;European Heart Journal Supplements;2016-11

2. Hyponatremia and Hypernatremia;Endocrinology: Adult and Pediatric;2016

3. Arginine vasopressin as a target in the treatment of acute heart failure;World Journal of Cardiology;2014

4. Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents;Drug Discovery Today;2010-10

5. The Critical Link of Hypervolemia and Hyponatremia in Heart Failure and the Potential Role of Arginine Vasopressin Antagonists;Journal of Cardiac Failure;2010-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP